Racial/ethnic disparities in antiretroviral treatment among HIV-infected pregnant medicaid enrollees, 2005-2007

American Journal of Public Health

Volumn 103, Issue 12, 2013, Pages

  Zhang, Shun ^a   Senteio, Charles ^b   Felizzola, Jesus ^c   Rust, George ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c AETC National Centers for HIV in Minority Communities   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CONFIDENCE INTERVAL; ETHNOLOGY; FACTUAL DATABASE; FEMALE; HEALTH CARE DISPARITY; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAID; PREGNANCY; RETROSPECTIVE STUDY; RISK; UNITED STATES; YOUNG ADULT; HIV SEROPOSITIVITY;

ADULT; AFRICAN AMERICANS; ANTI-HIV AGENTS; CONFIDENCE INTERVALS; DATABASES, FACTUAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTHCARE DISPARITIES; HISPANIC AMERICANS; HIV SEROPOSITIVITY; HUMANS; MEDICAID; ODDS RATIO; PREGNANCY; RETROSPECTIVE STUDIES; UNITED STATES; YOUNG ADULT;

EID: 84887274733     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2013.301328     Document Type: Article

References (60)

1. Racial/ethnic disparities in diagnoses of HIV/AIDS -33 states, 2001-2004. MMWR Morb Mortal Wkly Rep. 2006;55(5):121-125.
2. Lansky A, Brooks JT, DiNenno E, Heffelfinger J, Hall HI, Mermin J. Epidemiology of HIV in the United States. J Acquir Immune Defic Syndr. 2010;55(suppl 2):S64-S68.
3. Johnson AS, Wei X, Hu X, Dean HD. Epidemiology and surveillance of HIV infection and AIDS among non-Hispanic Blacks in the United States. In: McCree DH, Jones K, O'Leary A, eds. African Americans and HIV/AIDS. New York, NY: Springer; 2010: 15-30.
4. Hall HI, Song R, Rhodes P, et al. Estimation of HIV incidence in the United States. JAMA. 2008;300(5): 520-529.
5. Armstrong AW, Lam KH, Chase EP. Epidemiology of classic and AIDS-related Kaposi's sarcoma in the USA: Incidence, survival, and geographical distribution from 1975 to 2005. Epidemiol Infect. 2013;141(1):200-206.
6. Heron M. Deaths: leading causes for 2007. Natl Vital Stat Rep. 2011;59(8):1-95.
7. McDavid K, Li J, Lee LM. Racial and ethnic disparities in HIV diagnoses for women in the United States. J Acquir Immune Defic Syndr. 2006;42(1):101-107.
8. Centers for Disease Control and Prevention. HIV among women. Available at: Http://www.cdc.gov/hiv/topics/women/index.htm. Accessed March 1, 2013.
9. Lindegren ML, Byers RH Jr, Thomas P, et al. Trends in perinatal transmission of HIV/AIDS in the United States. JAMA. 1999;282(6):531-538.
10. Violari A, Cotton MF, Gibb DM, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008;359(21):2233-2244.
11. Bardeguez AD. Management of pregnancy in HIV-infected women and prevention of mother-to-child transmission. In: Smith KY, Rawlings MK, Ojikutu B, Stone V, eds. HIV/AIDS in US Communities of Color. New York, NY: Springer; 2009: 103-132.
12. HIV Perinatal Guidelines Working Group. Public Health Service Task Force: Recommendations for use of antiretroviral drugs in pregnant HIV-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. 2009. Available at: Http://aidsinfo.nih.gov/contentfiles/ lvguidelines/perinatalgl.pdf. Accessed December 31, 2009.
13. Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. 2011. Available at: Http://aidsinfo.nih.gov/contentfiles/lvguidelines/perinatalgl.pdf. Accessed July 31, 2012.
14. Foster CJ, Lyall EGH. Preventing mother-to-child transmission of HIV-1. Paediatr Child Health (Oxford). 2007;17(4):126-131.
15. Ciaranello AL, Perez F, Maruva M, et al.WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: Modeling clinical outcomes in infants and mothers. PLoS ONE. 2011;6(6):e20224.
16. Kong MC, Nahata MC, Lacombe VA, Seiber EE, Balkrishnan R. Association between race, depression, and antiretroviral therapy adherence in a low-income population with HIV infection. J Gen Intern Med. 2012;27 (9):1159-1164.
17. Crystal S, Sambamoorthi U, Merzel C. The diffusion of innovation in AIDS treatment: zidovudine use in two New Jersey cohorts. Health Serv Res. 1995;30(4): 593-614.
18. Van Dyke RB, Patel K, Siberry GK, et al. Antiretroviral treatment of US children with perinatally acquired HIV infection: Temporal changes in therapy between 1991 and 2009 and predictors of immunologic and virologic outcomes. J Acquir Immune Defic Syndr. 2011;57(2):165-173.
19. Kapogiannis BG, Soe MM, Nesheim SR, et al. Mortality trends in the US perinatal AIDS Collaborative Transmission Study (1986-2004). Clin Infect Dis. 2011;53(10):1024-1034.
20. Davis MH, O'Brien E. Profile of persons with disabilities in Medicare and Medicaid. Health Care Financ Rev. 1996;17(4):179-211.
21. Murray CJL, Kulkarni SC, Michaud C, et al. Eight Americas: Investigating mortality disparities across races, counties, and race-counties in the United States. PLoS Med. 2006;3(9):e260.
22. Pence BW, Reif S, Whetten K, et al. Minorities, the poor, and survivors of abuse: HIV-infected patients in the US deep South. South Med J. 2007;100(11):1114-1122.
23. International Classification of Disease, Ninth Revision, Clinical Modification. Hyattsville, MD: National Center for Health Statistics; 1980. DHHS publication PHS 80- 1260.
24. US Food and Drug Administration. National drug code directory. Available at: Http://www.fda.gov/cder/ndc. Accessed March 1, 2012.
25. US Department of Health and Human Services, Health Resources and Services Administration, Bureau of Health Professions. Area Resource File, 2009-2010.
26. US Department of Commerce. Federal Information Processing Standard, US Census Data. Available at: Http://quickfacts.census.gov/qfd/meta/long-fips.htm. Accessed July 9, 2013.
27. Hall SA, Kaufman JS, Ricketts TC. Defining urban and rural areas in US epidemiologic studies. J Urban Health. 2006;83(2):162-175.
28. Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK. Guidelines for using antiretroviral agents among HIVinfected adults and adolescents: The Panel on Clinical Practices for Treatment of HIV. Ann Intern Med. 2002; 137(5 pt 2):381-433.
29. Gilks CF, Crowley S, Ekpini R, et al. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet. 2006;368 (9534):505-510.
30. Schneider E, Whitmore S, Glynn K, Dominguez K, Mitsch A, McKenna MT. Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged < 18 months and for HIV infection and AIDS among children aged 18 months to < 13 years- United States, 2008. MMWR Recomm Rep. 2008;57 (RR-10):1-12.
31. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43 (11):1130-1139.
32. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8-27.
33. McCabe CJ, Goldie SJ, Fisman DN. The costeffectiveness of directly observed highly-active antiretroviral therapy in the third trimester in HIV-infected pregnant women. PLoS ONE. 2010;5(4):e10154.
34. Lau Y, Yin L. Maternal, obstetric variables, perceived stress and health-related quality of life among pregnant women in Macao, China. Midwifery. 2011;27 (5):668-673.
35. Centers for Disease Control and Prevention. New hope for stopping HIV. Vital Signs. 2011. Available at: Http://www.cdc.gov/vitalsigns/HIVtesting/index. html. Accessed July 1, 2012.
36. Heidari S, Mofenson L, Cotton MF, Marlink R, Cahn P, Katabira E. Antiretroviral drugs for preventing mother-to-child transmission of HIV: A review of potential effects on HIV-exposed but uninfected children. J Acquir Immune Defic Syndr. 2011;57(4):290-296.
37. Foust RF, Carey B. Achieving optimal maternal and infant health outcomes for Medicaid patients, with application for commercial populations. Manag Care Interface. 2002;15(6):45-50, 53-54.
38. Kuttner R. Health insurance coverage. N Engl J Med. 1999;340(2):163-168.
39. Levine RS, Briggs NC, Kilbourne BS, et al. Black-white mortality from HIV in the United States before and after introduction of highly active antiretroviral therapy in 1996. Am J Public Health. 2007;97(10): 1884-1892.
40. Shapiro MF, Morton SC, McCaffrey DF, et al. Variations in the care of HIV-infected adults in the United States. JAMA. 1999;281(24):2305-2315.
41. King WD, Minor P, Ramirez Kitchen C, et al. Racial, gender and geographic disparities of antiretroviral treatment among US Medicaid enrollees in 1998. J Epidemiol Community Health. 2008;62(9):798-803.
42. Centers for Disease Control and Prevention. HIV among Latinos. Available at: Http://www.cdc.gov/hiv/latinos/index.htm. Accessed July 1, 2012.
43. Gayle JA, Selik RM, Chu SY. Surveillance for AIDS and HIV infection among Black and Hispanic children and women of childbearing age, 1981-1989. MMWR CDC Surveill Summ. 1990;39(3):23-30.
44. Centers for Disease Control and Prevention. HIV/AIDS surveillance report, 2005. Rev ed. Atlanta, GA: US Department of Health and Human Services; 2007; 17:1-54.
45. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med. 1994;331(18):1173-1180.
46. Wade NA, Birkhead GS, Warren BL, et al. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. N Engl J Med. 1998;339(20):1409-1414.
47. Chen NE, Gallant JE, Page KR. A systematic review of HIV/AIDS survival and delayed diagnosis among Hispanics in the United States. J Immigr Minor Health. 2012;14(1):65-81.
48. Levy V, Prentiss D, Balmas G, et al. Factors in the delayed HIV presentation of immigrants in Northern California: Implications for voluntary counseling and testing programs. J Immigr Minor Health. 2007;9(1): 49-54.
49. Kelley CF, Hernandez-Ramos I, Franco-Paredes C, delRio C. Clinical, epidemiologic characteristics of foreign-born Latinos with HIV/AIDS at an urban HIV clinic. AIDS Read. 2007;17(2):73-74, 78-80, 85-88.
50. Bromley E, Nunes A, Phipps MG. Disparities in pregnancy healthcare utilization between Hispanic and non-Hispanic White women in Rhode Island. Matern Child Health J. 2012;16(8):1576-1582.
51. Krieger N. Does racism harm health? Did child abuse exist before 1962? On explicit questions, critical science, and current controversies: An ecosocial perspective. Am J Public Health. 2003;93(2):194-199.
52. James SA. Confronting the moral economy of US racial/ethnic health disparities. Am J Public Health. 2008;98(suppl 1):S16.
53. Marin G. AIDS prevention among Hispanics: needs, risk behaviors, and cultural values. Public Health Rep. 1989;104(5):411-415.
54. Ortega AN, Fang H, Perez VH, et al. Health care access, use of services, and experiences among undocumented Mexicans and other Latinos. Arch Intern Med. 2007;167(21):2354-2360.
55. Haviland AM, Elliott MN, Hambarsoomian K, Lurie N. Immunization disparities by Hispanic ethnicity and language preference. Arch Intern Med. 2011;171(2): 158-165.
56. Davern M, Quinn BC, Kenney GM, Blewett LA. The American Community Survey and health insurance coverage estimates: possibilities and challenges for health policy researchers. Health Serv Res. 2009;44(2 pt 1): 593-605.
57. Kaiser Commission on Medicaid and the Uninsured. Medicaid and SCHIP eligibility for immigrants. 2006. Available at: Http://www.kff.org/medicaid/ upload/7492.pdf. Accessed August 1, 2012.
58. Personal Responsibility and Work Opportunity Reconciliation Act of 1996, Pub L No. 104-193, 110 Stat 2105 (1996) (codified as amended in scattered sections of 42 USC).
59. Nachega JB, Leisegang R, Bishai D, et al. Association of antiretroviral therapy adherence and health care costs. Ann Intern Med. 2010;152(1):18-25.
60. Hammer SM. Antiretroviral treatment as prevention. N Engl J Med. 2011;365(6):561-562.